All In Biotech

Drug Trial Radar · NCT00595049

Pulmonary Artery Remodelling With Bosentan

Open Label, Non Comparative Study to Investigate the Effect of Bosentan on Pulmonary Artery Remodelling in Pulmonary Arterial Hypertension (PAH).

Last checked: Nov 20, 2026Latest source record: Jun 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

11

Actual

Start

May 31, 2006

Primary completion

Dec 31, 2008

Study completion Jun 30, 2010

Sponsor

Lead sponsor
ActelionJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jan 16, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to investigate whether bosentan (Tracleer®) affects the wall thickness of the pulmonary arteries in patients with idiopathic pulmonary arterial hypertension (iPAH) and PAH related to systemic sclerosis (PAH-SSc). The second purpose is to investigate if bosentan affects the enlargement of small vessels in the lungs in response to natural chemicals in patients with iPAH and PAH-SSc.

Conditions

  • Hypertension, Pulmonary

Interventions

  • bosentanDrug

    Bosentan 62.5 mg bid for 4 weeks, then 125 mg bid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline (BL) to 6 mths in the IVUS-derived measurement of pulmonary artery wall thickness.Time frame: Baseline to 6 months
  2. Change from BL to 6 mths in pulmonary microvascular circulation dilator responses to actylcholine (Ach).Time frame: Baseline to 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Royal Prince Alfred Hospital

    Camperdown, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.